Johns Hopkins Medicine

Daraxonrasib is the name of a drug for pancreas cancer that almost doubled survival for people with the disease in a clinical trial. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says while the drug is going …

A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read more →

Daraxonrasib is the name of a drug to treat pancreas cancer that has extended survival in many with the disease, a just reported clinical trial finds.  Johns Hopkins Kimmel Cancer Center director William Nelson says it’s gotten many people who treat …

A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read more →

New guidelines for managing cholesterol levels have recently been released by the American College of Cardiology. Cardiologist Roger Blumenthal at Johns Hopkins chaired the committee that wrote the guidelines, and says that in reviewing the data it became clear that …

Certain groups of people seem to be missing out when it comes to optimizing cardiovascular disease prevention, Elizabeth Tracey reports Read more →

Cholesterol found in your blood is just the beginning of the story when it comes to markers found there that are indicative of cardiovascular risk. A relative newcomer is apolipoprotein a, which is genetically determined, says Roger Blumenthal, a cardiologist …

What markers are found in blood that indicate cardiovascular risk? Elizabeth Tracey reports Read more →

When it comes to assessing your cardiovascular risk, your blood tells an eloquent story. It’s not just cholesterol but several other factors that can be detected and measured that point toward or away from risk. Roger Blumenthal, a cardiologist at …

What does a blood marker called lipoprotein A have to do with your risk for cardiovascular disease? Elizabeth Tracey reports Read more →

Cholesterol management, per new guidelines from the American College of Cardiology, is just one aspect of measures you can take to lower your risk for cardiovascular disease, the number one cause of death. Roger Blumenthal, a cardiologist at Johns Hopkins …

What’s involved in lowering your risk for cardiovascular disease? Elizabeth Tracey reports Read more →

The most important person in reducing your risk for cardiovascular disease is you, and managing your blood cholesterol levels is just one part of an overall, lifelong strategy, beginning with becoming educated about your own unique set of risk factors. …

Becoming educated about your own cardiovascular risk is pivotal to prevention, Elizabeth Tracey reports Read more →

Management of blood cholesterol is a major factor in the prevention of cardiovascular disease, as reflected in new guidelines released by the American College of Cardiology, and it should start early in life and be monitored throughout the lifespan. Johns …

Monitoring cholesterol and other factors should be done regularly to prevent cardiovascular disease, Elizabeth Tracey reports Read more →

When it comes to ideal LDL cholesterol levels in the blood, ideal is a bit of a moving target. Johns Hopkins cardiologist Roger Blumenthal, chair of an American College of Cardiology committee that has just updated cholesterol guidelines, says it …

What LDL cholesterol level should you be aiming for? Elizabeth Tracey reports Read more →